ciprofloxacin has been researched along with Ischemia in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Excerpt | Relevance | Reference |
---|---|---|
"The aims of this study were to evaluate factors influencing the distribution of ciprofloxacin in tissue of patients suffering from varying degrees of peripheral arterial disease (PAD)." | 3.83 | Factors Affecting Penetration of Ciprofloxacin in Lower Extremity Ischemic Tissues. ( Azzopardi, LM; Camilleri, L; Cassar, K; LaFerla, G; Serracino-Inglott, A; Vella, J; Vella, M, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vella, J | 1 |
Vella, M | 1 |
Cassar, K | 1 |
Camilleri, L | 1 |
Serracino-Inglott, A | 1 |
Azzopardi, LM | 1 |
LaFerla, G | 1 |
Assy, N | 1 |
Gefen, H | 1 |
Schlesinger, S | 1 |
Hussein, O | 1 |
Joukhadar, C | 1 |
Klein, N | 1 |
Frossard, M | 1 |
Minar, E | 1 |
Stass, H | 1 |
Lackner, E | 1 |
Herrmann, M | 1 |
Riedmüller, E | 1 |
Müller, M | 1 |
1 trial available for ciprofloxacin and Ischemia
Article | Year |
---|---|
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Angioplasty; Anti-Infective Agents; Area Under Curve; Arter | 2001 |
2 other studies available for ciprofloxacin and Ischemia
Article | Year |
---|---|
Factors Affecting Penetration of Ciprofloxacin in Lower Extremity Ischemic Tissues.
Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Debridemen | 2016 |
The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure.
Topics: Acetylcysteine; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Free Radical Scavengers | 2007 |